WTAP‐mediated m6A modification of circ₀032463 promotes osteosarcoma progression by sponging miR‐145‐5p and regulating GFRA1 expression

Osteosarcoma (OS) is the most frequent bone malignancy in humans. Previous evidence suggest that circ₀032463 is an oncogenic circular RNA (circRNA) in various cancers, including OS. However, the molecular mechanism of circ₀032463 involved in OS is still unclear. Circ₀032463, microRNA-145-5p (miR-145-5p), GDNF receptor alpha 1 (GFRA1), and Wilms tumor 1-associated protein (WTAP) levels were determined using real-time quantitative polymerase chain reaction (RT-qPCR). Cell proliferation, apoptosis, migration, invasion, and angiogenesis were analyzed using 5-ethynyl-2'-deoxyuridine (EdU), flow cytometry, transwell, and tube formation assays. Western blot analysis was performed to measure matrix metalloproteinase 2 (MMP2), MMP9, GFRA1, and WTAP protein levels. Binding between miR-145-5p and circ₀032463 or GFRA1 was confirmed using a dual-luciferase reporter and pull-down assay. The biological role of circ₀032463 on OS cell growth was also analyzed using a xenograft tumor model in vivo. Methylated RNA immunoprecipitation assay validated the interaction between WTAP and circ₀032463. Circ₀032463, GFRA1, and WTAP levels were increased, and miR-145-5p was decreased in OS tissues and cells. Circ₀032463 deficiency might hinder OS cell proliferation, migration, invasion, angiogenesis, and promote apoptosis in vitro. Mechanically, circ₀032463 worked as a miR-145-5p sponge to increase GFRA1 expression. Repression of circ₀032463 knockdown on tumor cell growth was proved in vivo. Besides, N6-methyladenosine (m6A) modification facilitates the biogenesis of circ₀032463. Taken together, m6A-mediated biogenesis of circ₀032463 facilitates OS cell malignant biological behavior partly via regulating the miR-145-5p/GFRA1 axis, suggesting a promising molecular marker for OS treatment.